EVO Stroller Recall Issued Due to Strangulation Risk
A recall has been issued for EVO infant strollers due to problems with the design, which could allow children to fall from the stroller and poses a potential strangulation hazard.
An EVO Stroller recall was announced by the U.S. Consumer Product Safety Commission (CPSC) on February 7, after it determined that a gap between the grab bar and seat bottom is large enough for an infant’s body to fall through if not harnessed. If the infant falls through the gap, he or she may also become trapped by the neck and strangle.
The recall includes EVO strollers with model numbers MT12-03, MT12-11, MT12-14, MT12-31, MT12-34, MT12-37, MT12-39, MT12-42, MT12-43 and MT12-48, which can be located on a white sticker underneath the stroller. The recalled models were sold with a black or silver colored metal frame and black, blue, white, or navy seats.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The EVO strollers were manufactured in China between February 2012 and November 2012, and were imported by Musty USA Inc., of Newark, New Jersey. The strollers were sold at juvenile product stores and online at Amazon.com between April 2012 and December 2012 for about $400.
This is at least the second stroller recall in less than a month. On January 15, Bugaboo Americas of El Segundo, California recalled more than 50,000 infant strollers after at least 58 reports were received that the carrying handles detached while in use, which may put babies in the strollers at risk of suffering a severe head trauma or other injury in a fall.
The CPSC recommends that consumers stop using the recalled EVO strollers immediately and contact Musty USA at (877) 546-9230 to receive and free replacement seat unit and grab bar that prevents the infant from falling. Consumers can also email the company at email@example.com or visit the company’s website at www.mutsy.com.
"*" indicates required fields
More Top Stories
A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.
A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to provide adequate warning about the risks of the thyroid eye disease drug.